Downstream Cellular Effects

In preclinical tumor models, MTX-101 leads to:
1. Suppression of Metabolic Flux
Reduced intracellular substrate levels result in decreased anabolic pathway activity and impaired biomass accumulation.

2. Energetic Stress Induction
Inhibition of nutrient transport triggers AMPK activation and metabolic stress signaling.

3. Reduced Proliferation
Tumor cell growth rates decline in a dose-dependent manner.

4. Apoptotic Sensitization

MTX-101 enhances susceptibility to metabolic stress-induced apoptosis and may increase sensitivity to combination therapies.